GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Entourage Health Corp (OTCPK:ETRGF) » Definitions » COGS-to-Revenue

Entourage Health (Entourage Health) COGS-to-Revenue : 1.58 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Entourage Health COGS-to-Revenue?

Entourage Health's Cost of Goods Sold for the three months ended in Dec. 2023 was $11.73 Mil. Its Revenue for the three months ended in Dec. 2023 was $7.42 Mil.

Entourage Health's COGS to Revenue for the three months ended in Dec. 2023 was 1.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Entourage Health's Gross Margin % for the three months ended in Dec. 2023 was -58.11%.


Entourage Health COGS-to-Revenue Historical Data

The historical data trend for Entourage Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entourage Health COGS-to-Revenue Chart

Entourage Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 1.82 1.28 1.49 0.91

Entourage Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.43 0.66 0.70 0.72 1.58

Entourage Health COGS-to-Revenue Calculation

Entourage Health's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=27.583 / 30.347
=0.91

Entourage Health's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=11.732 / 7.42
=1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entourage Health  (OTCPK:ETRGF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Entourage Health's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 11.732 / 7.42
=-58.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Entourage Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Entourage Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Entourage Health (Entourage Health) Business Description

Traded in Other Exchanges
Address
250 Elm Street, Aylmer, ON, CAN, N5H 2M8
Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.